| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |